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Protein biochemistry protocols typically include disulfide bond reducing agents to guard against
unwanted thiol oxidation and protein aggregation. Commonly used disulfide bond reducing agents
include dithiothreitol, β-mercaptoethanol, glutathione, and the tris(alkyl)phosphine compounds
tris(2-carboxyethyl)phosphine (TCEP) and tris(3-hydroxypropyl)phosphine (THPP). While
studying the catalytic activity of the NAD(P)H-dependent enzyme Δ1-pyrroline-5-carboxylate
reductase, we unexpectedly observed a rapid non-enzymatic chemical reaction between NAD+
and the reducing agents TCEP and THPP. The product of the reaction exhibits a maximum
ultraviolet absorbance peak at 334 nm and forms with an apparent association rate constant of
231–491 M−1 s−1. The reaction is reversible, and nuclear magnetic resonance characterization
(1H, 13C, and 31P) of the product revealed a covalent adduct between the phosphorus of the
tris(alkyl)phosphine reducing agent and the C4 atom of the nicotinamide ring of NAD+. We
also report a 1.45 Å resolution crystal structure of short-chain dehydrogenase/reductase with the
NADP+–TCEP reaction product bound in the cofactor binding site, which shows that the adduct
can potentially inhibit enzymes. These findings serve to caution researchers when using TCEP or
THPP in experimental protocols with NAD(P)+. Because NAD(P)+-dependent oxidoreductases are
widespread in nature, our results may be broadly relevant.

Author Manuscript

Tris(alkyl)phosphine compounds such as tris(2-carboxyethyl)phosphine (TCEP) and tris(3
hydroxypropyl)phosphine (THPP) have become widely used as disulfide reducing agents in
protein biochemistry research.1–5 TCEP and THPP have gained in popularity because of
their several advantages over the classical reducing agent dithiothreitol (DTT, Cleland’s
reagent), including irreversible reduction of disulfides, higher water solubility, lower
susceptibility to oxidation, and a greater ability to reduce a wide range of disulfide substrates
to their corresponding thiols.6,7 TCEP and THPP are typically used at ≤1.0 mM during
protein purification and long-term storage of proteins, whereas in other applications such as
enzyme assays, protein crystallography, protein refolding, and cysteine proteomic studies,
the concentrations can be considerably higher (5–50 mM).4,8–12 We suspect that most
biochemistry researchers, like us, have assumed that TCEP and THPP are innocuous.

Author Manuscript

We routinely use TCEP and THPP in the purification of human L-Δ1-pyrroline-5-carboxylate
(L-P5C) reductase (PYCR), an enzyme that reduces L-P5C to L-proline using NAD(P)H.
PYCR catalyzes the last step of L-proline biosynthesis and is important in the plant
stress response13 and bacterial pathogenesis14 and, in humans, is of significant interest
in bioenergetics and cancer research.15–19 Because L-P5C is not commercially available or
amenable for long-term storage, the activity of PYCR in the reverse direction is sometimes
studied using L-proline or the analogue L-thiazolidine-4-carboxylic acid (L-T4C) as the
substrate, and NAD(P)+ as the hydride-accepting cofactor.20–23 Assaying PYCR in the
reverse direction is attractive for high-throughput screening of compound libraries seeking
to identify small molecule inhibitors of PYCR.24 We therefore sought to test the reverse
activity of human PYCR1 and PYCR2 isoforms. In our assays, however, we did not
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find reverse activity with NAD(P)+ and L-proline. Instead, we unexpectedly discovered a
chemical reaction between NAD+ and tris(alkyl)phosphine compounds.
PYCR1 and PYCR2 reverse activity with L-proline and NAD+ was tested, but no evidence
for NADH formation was observed (SI Figure 1). Learning that some protocols for PYCR
reverse activity include TCEP,24 we added THPP or TCEP to the assay and observed a rapid
increase in absorbance around 340 nm (SI Figure 1). Suspecting a non-enzymatic reaction,
we repeated the assay without PYCR, and again a sharp increase in absorbance at 340 nm
was observed with THPP or TCEP (SI Figure 2).

Author Manuscript

Because the absorbance increase occurred shortly after the addition of TCEP and THPP, we
examined the reaction by stopped-flow ultraviolet–visible spectrophotometry. Upon rapidly
mixing THPP or TCEP with NAD+, we detected an absorbance peak at 334 nm within 200
ms (Figure 1a,b). Rate constants for the observed increase at 334 nm were then determined
for TCEP and THPP. NAD+ was rapidly mixed with increasing concentrations of THPP
and TCEP. The observed rate constant (kobs) versus THPP (Figure 1c) and TCEP (Figure
1d) concentration was then plotted to determine the apparent forward association (k+app)
and reverse dissociation (k−app) rate constants. SI Table 1 summarizes the rate constants
and shows that both the forward (491 M−1 s−1) and reverse (24 s−1) rate constants with
TCEP are faster than with THPP. The equilibrium association constant (Kaapp), however,
is slightly higher with THPP (35 M−1) than with TCEP (20 M−1). The reaction between
NAD+ and TCEP (25 mM) was repeated in different buffers, and similar kobs values in the
range of 30–35 s−1 for the increase at 334 nm were obtained, indicating product formation is
independent of the buffer composition (SI Figure 3).

Author Manuscript

We next considered the possibility that TCEP and THPP had reduced NAD+ to NADH. L
Lactate dehydrogenase (LDH) and pyruvate were added to the TCEP/THPP–NAD+ reaction
product, but no decrease in absorbance (330–340 nm) was observed, indicating that the
product was not used by L-lactate dehydrogenase to catalyze the reduction of pyruvate. We
also did not find evidence for NADH as the reaction product by mass spectrometry analysis.

Author Manuscript

Nuclear magnetic resonance (NMR) was then used to characterize and identify the product
of the reaction between TCEP or THPP and NAD+. Initial NMR experiments included one
dimensional (1H and 31P) and two-dimensional (1H–31P HSQC and 1H–31P HSQC-TOCSY)
analyses (Figure 2 and SI Figure 5; corresponding spectral data summarized in SI Table
4). The resulting data showed through-bond coupling of the phosphorus nucleus of THPP
to protons of the nicotinamide ring of NAD+. Additionally, the 1H–31P HSQC-TOCSY
data in SI Figure 5 indicate the reaction was reversible as there were 31P correlations for
both the covalent adduct nicotinamide ring protons and the lone NAD+ nicotinamide ring
protons. 1H–31P HSQC-TOCSY correlations to NAD+ nicotinamide ring protons meant the
tris(alkyl)phosphine compound dissociated from the nicotinamide ring during the TOCSY
spin lock.
Both one-dimensional (31P) and two-dimensional (1H–31P HSQC and 1H–31P HSQC
TOCSY) NMR analyses showed phosphorus signals at 34 and −13 ppm for the NAD+
and THPP reaction mixture. The phosphorus nuclei at 34 ppm show through-bond coupling
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to the nicotinamide ring protons of NAD+, as previously described. The phosphorus signals
at −13 ppm are attributed to the phosphates in ADP; as expected, these phosphorus nuclei
show through-bond coupling to ribose ring protons.

Author Manuscript

To further confirm the structural assignment, additional NMR experiments were conducted
on the NAD+ and THPP reaction mixture. The sample had been stored at 4 °C for
3 weeks and showed minor decomposition; however, the reaction product was still the
main component. These additional experiments included one-dimensional (13C) and two
dimensional (1H–1H COSY, 1H–1H TOCSY, 1H–13C HSQC, and 1H–13C HMBC) analyses
(SI Figures 6 and 7 and SI Table 5). The additional data indicated that THPP attacked C4 of
the nicotinamide ring of NAD+, the same position at which hydride transfer occurs, resulting
in two diastereomers in an ~1:0.6 ratio (Figure 3a). NMR analyses of NAD+ alone and
NADH alone (spectral data summarized in SI Tables 2 and 3, respectively) also support
these structural assignments. Lastly, the one-dimensional proton spectra of the reaction
product of NAD+ with THPP and TCEP were very similar (SI Figure 4), indicating a similar
covalent adduct is formed with both tris(alkyl)phosphine compounds (Figure 3a,b).

Author Manuscript

The covalent adduct between NADP+ and TCEP was also characterized in the context of an
oxidoreductase active site using X-ray crystallography. The 1.45 Å resolution structure of
a short-chain dehydrogenase/reductase (SDR) from Burkholderia ambifaria was determined
from a crystal grown in the presence of 5 mM NADP+ and 1 mM TCEP (Protein Data Bank
entry 5VPS). Whereas NADP+ was explicitly added to the crystallization experiment to
obtain a structure of the functional enzyme, TCEP was included as an innocuous component
of the enzyme stock solution buffer. The electron density maps clearly showed NADP+
bound to the Rossmann fold in the expected conformation (Figure 4a). Unexpectedly, strong
electron density indicated that the NADP+ cofactor had been covalently modified at the
C4 atom of the nicotinamide ring (Figure 4b). The electron density is consistent with the
structure of the adduct determined from solution NMR. The structure shows that several
active site residues form hydrogen bonds and ion pairs with the carboxyethyl groups of the
TCEP (Figure 4b). These results suggest that the reaction of tris(alkyl)phosphine reducing
agents with NAD(P)+ inactivates the biological cofactor and that the species generated can
potentially inhibit enzymes.

Author Manuscript

To the best of our knowledge, this is the first characterization of a covalent adduct between
NAD(P)+ and TCEP or THPP. The reaction occurs at physiological pH within a range of
concentrations of TCEP and THPP (0.5–50 mM) typically used in protein biochemistry
and structural biology experiments. The reaction is reversible and occurs on a time scale
comparable to that of TCEP reduction of disulfide bonds in DTT (43 M−1 s−1), peptide
substrates containing a CXXC motif (650 M−1 s−1), and oxidized cysteines in proteins (1.5–
813 M−1 s−1).4,9 The reaction between NAD+ and TCEP or THPP most likely proceeds
through a nucleophilic attack by the phosphine at the C4 atom of the nicotinamide ring
similar to that of a tertiary phosphine attacking an alkyl halide to form a phosphonium
ion. The nicotinamide ring of NAD+ has electrophilic character and is susceptible to
modifications by nucleophiles. Biologically relevant is the fact that sulfhydryl compounds
such as cysteine and glutathione can form adducts at the C4 atom of the nicotinamide with
absorbance maxima at 330–335 nm.25,26 In urocanase, a covalent intermediate between
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imidazolepropionate and NAD+ exhibited an absorbance peak at 335 nm.27 In that case,
NMR showed that the imidazole nitrogen formed a covalent adduct at the C4 atom of the
nicotinamide ring. The absorbance peak of 334 nm observed here for the covalent NAD–
phosphine adduct is similar to that previously reported for various covalent NAD species.
NAD addition reactions are also known for cyanide, bisulfite, and dihydroxyacetone.28 LDH
has been shown to catalyze NAD adduct formation with cyanide and pyruvate.29 The NAD–
pyruvate adduct inhibits LDH at high concentrations of pyruvate.29 Other examples include
isoniazid–NAD/NADP adducts found in Mycobacterium tuberculosis that inhibit different
enzymes such as dihydrofolate reductase.30

Author Manuscript

We showed that tris(alkyl)phosphine reducing agents inactivate the biological cofactor
NAD(P)+, and the inactivated cofactor can, at least in one case, bind the active site of
an enzyme. These results suggest that including TCEP or THPP in crystallization trials
of NAD(P)+-dependent oxidoreductases could have unintended consequences. In the SDR
structure, the active site is large enough to accommodate the bulky TCEP group, and several
residues serendipitously stabilize the carboxyethyl groups (Figure 4). In other enzymes,
the adduct may be too large to fit in the active site, which could result in weak or no
electron density for NAD(P)+ despite the inclusion of the cofactor in the crystallization
setup. One can also imagine cases in which the covalent modification causes the cofactor
to bind in an atypical pose, making it difficult to infer the biochemical significance of the
structure. Finally, even if the adduct does bind to the enzyme in crystallo, if the active site
cannot stabilize the conformation of the tris(alkyl)-phosphine molecule, the nicotinamide
may appear disordered, which would complicate the interpretation of the structure.

Author Manuscript
Author Manuscript

TCEP and THPP could also cause problems with enzyme assays and binding studies.
To illustrate how TCEP could interfere with the assay of a dehydrogenase, we measured
the activity of glucose-6-phosphate dehydrogenase (G6PDH) in the presence of 1–50
mM TCEP. With the glucose 6-phosphate concentration fixed at 5 mM and the NAD+
concentration varying from 0.25 to 0.4 mM, the apparent reaction velocity steadily
decreased with an increase in TCEP concentration at all NAD+ concentrations tested (SI
Figure 8). The effect of TCEP was more pronounced at the lower NAD+ concentrations and
was significant even at the lowest TCEP concentration tested. For example, the inclusion
of 1 mM TCEP decreased the apparent rate by ~20% when NAD+ was used in the range
of 0.025–0.2 mM. The artifactual underestimation of the catalytic activity is presumably
due to the reaction of TCEP with NAD+ decreasing the effective concentration of the
latter. Another potential problem is that adding TCEP or THPP to NAD(P)+-dependent
assays can generate a rapid absorbance increase around 340 nm that, without proper
controls, could be misinterpreted as enzyme activity. This particularly could be a problem
in enzyme-coupled reactions using NAD+/NADP+ and high-throughput assays that use only
end point measurements. Also, the adduct may inhibit the enzyme, as implied by the SDR
structure (Figure 4). With regard to binding studies, the addition of tris(alkyl)phosphine
compounds would potentially lead to lower concentrations of free NAD(P)+, as in the
glucose-6-phosphate dehydrogenase example (SI Figure 8), resulting in anomalous errors
in the determined binding constant. In addition, data analysis could be complicated by
unknowingly having two species present, NAD(P)+ and the NAD(P)+–tris(alkyl)phosphine
covalent adduct. Methods that measure changes in heat to quantify binding events, such as
Biochemistry. Author manuscript; available in PMC 2021 October 20.
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isothermal titration calorimetry, would have complications due to the heat of the reaction
between NAD(P)+ and TCEP or THPP.31
In summary, we characterized the chemical reaction kinetics of NAD+ and
tris(alkyl)phosphines. Evidence from stopped-flow spectrophotometry, multidimensional
NMR, and X-ray crystallography indicates that the product is a reversible covalent adduct
between the phosphorus of the tris(alkyl)-phosphine and the C4 atom of the NAD+
nicotinamide. Altogether, our findings here serve as a cautionary note when using TCEP and
THPP in biological assays and structural studies of NAD(P)+-dependent oxidoreductases.
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L-P5C

L-Δ1-pyrroline-5-carboxylate
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L-Δ1-pyrroline-5-carboxylate

PYCR1/2

human L-Δ1-pyrroline-5-carboxylate reductase 1/2

SDR

short-chain dehydrogenase/reductase

TCEP

tris(2-carboxyethyl)phosphine
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tris(3-hydroxypropyl)phosphine

reductase
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Figure 1.
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Stopped-flow kinetics of the NAD+–tris(alkyl)phosphine reaction. NAD+ (0.5 mM) was
rapidly mixed with 50 mM (a) THPP and (b) TCEP in 100 mM HEPES (pH 7.5) buffer.
Plots of absorbance at 334 nm fit to a single-exponential equation are shown in the insets
along with the observed rate constant (kobs). The dependence of kobs on THPP and TCEP
concentration was determined by holding the NAD+ concentration at a fixed value (0.5 mM)
and varying the THPP and TCEP concentration (5–150 mM). kobs values were determined
from single-exponential fits of single-wavelength data collected at 334 nm. The apparent
forward association (k+app) and reverse dissociation (k−app) rate constants were determined
from the plot of kobs vs (c) THPP and (d) TCEP concentration. Data are plotted as the
mean ± the standard deviation of three technical replicates and fit to a linear equation. All
concentrations are after mixing.
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Figure 2.

Two-dimensional 1H–31P HSQC spectrum of the NAD+ and THPP reaction mixture. The
spectrum was acquired with a J(HP) coupling constant of 11 Hz.
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Figure 3.
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Chemical structures of the reaction products. Resolved covalent adduct products from the
reaction of (a) NAD+ with THPP and (b) NAD+ with TCEP.
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Figure 4.
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Structure of B. ambifaria SDR with a NADP+–TCEP adduct in the active site. (a) Cartoon
drawing of the protein with the adduct colored pink. The inset shows electron density for
the adduct (Polder omit, 3.0σ). (b) Close-ups of the adduct showing electron density for the
P–C4 bond (left) and interactions with the carboxyethyl groups (right).
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EXPERIMENTAL PROCEDURES
Materials and Reagents
MilliQ-Ultra purified water was used for the preparation of all buffers and chemicals in
the experiments. The following reagents were purchased from Millipore-Sigma:
NaH2PO4, ε-Amino-N-Caproic Acid, N-tosyl-L-phenylalanine chloromethyl ketone,
bovine serum albumin, pyruvate, L-lactate dehydrogenase, NADPH, NADH, and NH4F.
The following reagents were commercially available from Fisher Scientific: NaOH, NaCl,
2-[4(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES), Na2CO3, NaHCO3, and
ethylenediamine tetraacetic acid (EDTA) disodium salt. Reagents β-octyl-Dglucopyranoside (β-OG) and L-proline were commercially available from Combi-Blocks.
Ethanol
(190or
200-proof)
was
purchased
from
Decon
Labs.
Tris(hydroxymethyl)aminomethane (Tris), glycine, isopropyl β-D-thiogalactopyranoside
(IPTG), phenylmethylsulfonyl fluoride (PMSF), leupeptin hemisulfate, and NAD+ were
purchased from Gold Biotechnology. Imidazole and o-aminobenzaldehyde (o-AB) were
purchased from Acros Organics. In terms of tris(alkyl) phosphine reducing agents used
in this study, Tris(3-hydroxypropyl)phosphine (THPP) was purchased from Strem
Chemicals, and the hydrochloride salt of Tris(2-carboxyethyl)phosphine (TCEP-HCl)
was purchased from ThermoFisher Scientific-Pierce Biotech.
Stock solutions of NADH and NAD+ were prepared in 10 mM Tris-HCl (pH 8) and stored
at -80 °C. NADH and NAD+ concentrations were determined spectrophotometrically at
wavelengths 340 nm (ε340 = 6220 M-1cm-1)1 and 260 nm (ε260 = 17,370 M-1cm-1),2
respectively. Stock solutions of each tris(alkyl)phosphine reducing agent, THPP and
TCEP, were made at pH 7.5 in 0.1 M Tris-HCl (pH 7.5) buffer and stored at -80 °C.
PYCR and reversible activity assays
Human PYCR1 (UniProt ID P32322) was expressed and purified as described
previously.3 Similarly, PYCR2 (UniProt ID Q96C36) was expressed from a pKA8HPYCR2 construct in E. coli BL21 (DE3) pLysS competent cells (Novagen-EMD Millipore
Sigma), cultured in TB liquid media and induced with 0.4 mM IPTG. After centrifugation,
cell pellets were resuspended in NPI-5 cell lysis buffer (5 mM imidazole, 500 mM NaCl,
50 mM NaH2PO4, pH 7.5) supplemented with 500 µM THPP, 0.01% TritonX-100
detergent (Amresco), 0.01% Brij-35 polyoxyethylene detergent (Santa-Cruz
Biotechnology), 10 mM β-OG, and a mixture of five protease inhibitors. The cell
suspension was then subjected to sonication to lyse the cells followed by centrifugation
at 4 °C. The supernatant was then applied to a Ni-NTA Superflow (Qiagen) affinity
column for purification PYCR2.
The ability of human PYCR1 and PYCR2 to catalyze the reverse reaction (L-proline +
NAD+  L-P5C + NADH) was tested in 0.1 M Tris-HCl (pH 7.5) buffer containing 0.01%
(v/v) Brij-35 detergent, 30 mM MgCl2, 5 mM L-proline, and 0.5 mM NAD+, and with or
without tris(alkyl)phosphine compound (1 mM TCEP (pH 7.5) or 1 mM THPP (pH 7.5)).
Assays (600 µl total volume) were performed at room temperature and initiated by
adding PYCR enzyme (0.06 µM final concentration). Reaction components were kept
covered with aluminum foil to protect from ambient light and the assays were performed
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in the dark. Reactions were monitored at 340 nm for 30 min in a 1-cm path length quartz
cuvette (Starna Cells) using a Varian Cary 50-UV/VIS spectrophotometer (Agilent
Technologies).
Glucose-6-phosphate dehydrogenase (G6PDH) assays
G6PDH from Leuconostoc mesenteroides was purchased from Millipore-Sigma (catalog
number G5760-1KU). Assays were performed in an Epoch 2 plate reader (BioTek,
Winooski, VT, USA) by monitoring NADH at 340 nm. Each assay contained G6PDH
(2000x dilution), 5 mM G6P, and variable amounts of NAD+ and TCEP in 50 mM MOPS
(pH 7.4) buffer.
NAD+ reactions with tris(alkyl)phosphine reagents
Reactions of NAD+ with THPP and TECP were initially performed at room temperature
under dark conditions similarly to the PYCR enzyme assays above except that no
enzyme was added. Reaction components (0.5 mM NAD+ and 5 mM L-proline) were
incubated in 0.1 M Tris-HCl buffer (pH 7.5, 0.01% (v/v) Brij-35 detergent, 30 mM MgCl2)
for 15 min in a quartz cuvette followed by the addition of THPP and TCEP (1 mM final
concentration). The absorbance at 340 nm was monitored for a total of 30 min using a
Varian Cary 50-UV/VIS spectrophotometer.
Stopped-flow kinetics of the reaction between NAD+ and THPP and TCEP were
performed in the dark with different reaction buffers of 100 mM (pH 7.5) HEPES, TrisHCl, Na-phosphate, and PBS. All stopped-flow experiments were conducted on a HiTech Scientific SF-61DX2 stopped-flow instrument equipped with a photodiode array
detector and KinetAsyst software. The temperature of the mixing chamber for all
experiments was maintained at room temperature (23 oC). NAD+ (0.5 mM final
concentration) was rapidly mixed with THPP or TCEP (25 mM final concentration) and
the reaction was monitored in the stopped-flow instrument by multiwavelength
absorption in the range of 300-700 nm. In another set of experiments, NAD+ was held
fixed at 0.5 mM (after mixing) while increasing the concentrations of THPP and TCEP
(5-150 mM after mixing) in 100 mM HEPES (pH 7.5) buffer and monitoring the reaction
by single wavelength data collection at 334 nm. The average of three collected traces
(n=3 technical replicates) was fit by non-linear least-squares regression to a single 3parameter exponential rise equation using SigmaPlot 12.0 (version 12.0.0.182, Systat
Software). The observed rate constant (kobs) from the single exponential fitting was then
plotted versus THPP and TCEP concentrations from which the apparent second order
rate constant for the forward step of the reaction (k+app) was determined by linear least
squares fit analysis. The apparent first-order rate constant for the reverse step of the
reaction (k−app) was determined by the intercept at the vertical axis. Under the pseudofirst-order conditions of the stopped-flow experiments ([THPP or TCEP] >> [NAD+]):
kobs = (k+app) [THPP or TCEP] + (k−app)
and the apparent association equilibrium constant is defined as Kaapp = (k+app/k−app).4
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Nuclear Magnetic Resonance (NMR) characterization of the reaction product
For NMR measurements, the reaction of NAD+ with THPP and TCEP was performed in
100 mM NaHCO3-Na2CO3 (pH 7.5) buffer. The reaction was protected from ambient
light by performing all steps in the dark and covering the samples with aluminum foil.
Samples were made by reacting NAD+ (30.6 mM) or NADH (25.3 mM) with THPP or
TCEP (400 mM) and kept on ice prior to NMR measurements. We prepared each
reaction component individually as well as in approximate (1:1) volume combinations of
NAD+ to THPP and TCEP. The total sample volume was 500 µL, including 50 µL
deuterium oxide that was added for spectrometer lock. NMR experiments that were
performed include: one-dimensional 1H, 13C, and 31P, as well as two-dimensional 1H-1H
COSY, 1H-1H TOCSY, 1H-31P HSQC-TOCSY, 1H-31P HSQC, 1H-13C HMBC, and 1H-13C
HSQC. The NMR spectra were acquired on a Bruker Avance 600 MHz NMR
spectrometer with a 5 mm TXI or 5 mm BBO probe, held at 4 oC. All spectra were
acquired under dark lab conditions with overhead lights off the entire time.
Crystal structure determination of short-chain dehydrogenase/reductase (SDR)
The gene BamMC406_2208 (UniProt ID B1YU47) from Burkholderia ambifaria strain
MC40-6 encodes a 259 amino acid long open reading frame (ORF) annotated as a
short chain dehydrogenase/reductase SDR. The gene was cloned from genomic DNA
into the BG1861 expression vector which encodes an N-terminal hexahistidine affinity
tag; the full polypeptide sequence is MAHHHHHH-(ORF). The protein was expressed
and purified using a general expression and purification protocol detailed previously.5, 6
The protein was expressed in BL21 (DE3) R3 Rosetta E. coli cells. The protein was
purified by nickel immobilized metal affinity chromatography (Ni-IMAC) followed by size
exclusion chromatography (SEC) in 20 mM HEPES pH 7.0, 300 mM NaCl, 1 mM TCEP,
and 5% v/v glycerol, concentrated to 16.34 mg/ml, and stored at -80 °C prior to
crystallization experiments. The SSGCID target identifier is BuamA.00010.o and the
SSGCID construct identifier is BuamA.00010.o.B1 with a protein batch number of
PS38204. The plasmid and the protein are available (www.ssgcid.org/availablematerials/). Crystals of BuamA.00010.a.B1 were grown at 20.8 mg/mL with 5 mM
NADP using the sitting drop vapor diffusion method at 14 °C. Equal volumes of the
protein and precipitant were equilibrated against 80 µL of reservoir in Compact Jr 96well crystallization plates from Rigaku Reagents. The crystals were obtained from the
MCSG1 crystallization screen (Microlytic, now Anatrace) in 100 mM potassium tartrate
with 25% PEG 3350. The crystals were harvested into reservoir supplemented with 8
mM NADP and 20% ethylene glycol as cryo-protectant then flash frozen in liquid
nitrogen. A data set was obtained at the Advanced Light Source beamline 8.2.1
equipped with an ADSC quantum 315r CCD detector at a wavelength of 1.00 Å under a
stream of nitrogen (100K). Data were reduced with XDS/XSCALE.7 The structure was
determined by molecular replacement in Molrep8 using PDB ID 5IDX (SSGCID, no
primary citation) as a search model. The final model was obtained after numerous
iterative rounds of refinement in Phenix9 and manual model building in Coot.10 The
coordinates and structure factor files have been deposited to the Protein Data Bank with
PDB ID 5VPS. X-ray diffraction images are available at the Integrated Resource for
Reproducibility in Macromolecular Crystallography (www.proteindiffraction.org).
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SI Table 1. Pre-steady-state kinetic parameters for the reaction of NAD+ and
tris(alkyl)phosphine compounds
Kinetic parameter

THPP

TCEP

k+ app (M-1 s-1)a

231 ± 6

491 ± 25

k- app (s-1)b

6.6 ± 0.4

24 ± 2

Ka app (M-1)c

35 ± 2

20 ± 2

a

Value ± Std error is reported for the apparent forward rate constant determined as the slope of
the plotted data fit to a linear least-squares equation using SigmaPlot 12.0 (version 12.0.0.182,
Systat Software) with data plotted as (mean ± SD) of n=3 technical replicates
b
Value ± Std error is reported for the apparent reverse rate constant determined as the vertical
axis intercept of the plotted data
c
Apparent equilibrium association constant determined from the calculation of Kaapp = (k+app/k−app)
SI Table 2. NMR data from 1H-13C correlation experiments† of NAD+
Label

δ (1H, ppm)‡

δ (13C, ppm)

HMBC

2

9.1 (s, 1H)

138.0

3, 4, 6, 7, 8

3

131.6

4

8.57 (d, 1H, 8.5 Hz)

143.6

2, 6, 7

5

7.93 (at, 1H, 6.6 Hz)

126.6

3, 6

6

8.9 (d, 1H, 6.6 Hz)

140.3

2, 4, 5, 8

7
8

163.2
5.85 (d, 1H, 5.6 Hz)

98

†

2, 6

Chemical shifts were determined from the one dimensional 1H and 13C experiments.
Correlations were determined from 1H-13C HSQC and HMBC experiments and correspond to
site labels shown above in NAD+ structure.
‡
Listed next to each 1H-NMR chemical shift value is (multiplicity designation [s, singlet; d,
doublet; etc.], integral value, and J-coupling constant).
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SI Table 3. NMR data from 1H-13C correlation experiments† of NADH
Label

δ (1H, ppm)‡

δ (13C, ppm)

HMBC

2'

6.68 (s, 1H)

136.7

3', 4', 6', 7', 8'

3'

97.5

4'

2.35 (dd, 1H, 3.4 and 18.8 Hz), 2.49 (d, 1H, 18.4 Hz)

19.9

2', 3', 5', 6'

5'

4.51 (1H)

103.4

3', 6'

6'

5.73 (d, 1H, 8.4 Hz)

121.4

2', 4', 5', 8'

7'
8'

170.7
4.55 (d, 1H, 7.1 Hz)

93.1

†

2', 6'

Chemical shifts were determined from the one dimensional 1H and 13C experiments.
Correlations were determined from the HMBC experiment and correspond to site labels shown
above in NADH structure.
‡
Listed next to each 1H-NMR chemical shift value is (multiplicity designation [s, singlet; d,
doublet; dd, doublet of doublets], integral value, and J-coupling constant).
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SI Table 4. NMR data from 1H-31P correlation experiments† of NAD+ and THPP reaction
mixture
δ (1H-31P HSQC,
ppm)

δ ( 1H-31P HSQCTOCSY, ppm)

Label

δ (1H, ppm)‡

2

9.11 (s)

2''

7.10 (d, 1H, 1.8 Hz), minor 7.23 (d, 1H,
J = 1.8 Hz)

4

8.59 (d, J = 8.4 Hz)

4''

3.96 (1H), minor 4.35

6

8.91 (d, J = 6.3 Hz)

6''

6.33 (at, 1H, J = 6.3 Hz), minor 6.28
(at, 1H J = 6.3)

34.3, minor 34.4

34.3, minor 34.4

9''

1.96 (m), minor 1.98

34.3

34.3

10''

1.54 (m)

34.3

34.3

11''

3.44 (m)

34.3
34.3, minor 34.4

34.3, minor 34.4
34.3

34.3, minor 34.4

34.3, minor 34.4
34.3

34.3

†

Chemical shifts were determined from the one dimensional 1H and 31P experiments.
Correlations were determined from 1H-31P HSQC and HSQC-TOCSY experiments shown in Fig.
2 and SI Fig. 5, respectively and correspond to site labels shown above in the NAD+ structure
and NAD+─THPP reaction product structure.
‡
Listed next to each 1H-NMR chemical shift value is (multiplicity designation [s, singlet; d,
doublet; m, multiplet; etc.], integral value, and J-coupling constant).
Note the 1H-31P HSQC-TOCSY correlations listed here correspond to both NAD+─THPP
reaction product protons and to NAD+ protons.
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SI Table 5. NMR data from 1H-13C correlation experiments† of NAD+ and THPP reaction
mixture
Label

δ (1H, ppm)‡

δ (13C, ppm)‡

HMBC

2''

7.10 (d, 1H, 1.8 Hz), minor 7.23 (d,
1H, 1.8 Hz)

139.3, minor 134.5

3'', 4'', 6'', 7'', 8''

3''

94.6

4''

3.96 (1H), minor 4.35

28.4 (47 Hz), minor 28.6
(48 Hz)

2'', 3'', 5'', 6'', 7''

5''

4.51

93.9

4'', 6''

6''

6.33 (at, 1H, 6.3 Hz), minor 6.28 (at,
1H, 6.3 Hz)

126.6, minor 132.6

2'', 4'', 5'', 8''

7''

168.2

8''

4.67 (broad s), minor 4.69

9''

1.96 (m), minor 1.98

10''

1.54 (m)

11''

3.44 (m)

92.6, minor 92.3
11.3 (44 Hz), minor 11.1
(45 Hz)
21.6 (4 Hz), minor 21.8 (4
Hz)
59.3

†

2'', 6''
10'', 11''
9'', 11''
9'', 10''

Chemical shifts were determined from the one dimensional 1H and 13C experiments.
Correlations were determined from 1H-13C HSQC and HMBC experiments shown in SI Fig. 7
and correspond to site labels shown above in the NAD+─THPP reaction product structure.
‡
Listed next to each 1H-NMR or 13C-NMR chemical shift value is (multiplicity designation [s,
singlet; d, doublet; m, multiplet; etc.], integral value, and J-coupling constant).
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SI Table 6. X-ray diffraction data collection and refinement statistics
Parameter
PDB ID

5VPS

Space group

P42212

Unit-cell parameters
a = b (Å)

64.09

c (Å)

119.17

α = β= 

90º

Matthews coefficient (Å3Da-1) 2.22
Solvent content (%)

44.5

Resolution range (Å)

50 – 1.45 (1.49 – 1.45)a

Mean I/(I)

30.0 (3.44)

No. of observed reflections

44,832 (3280)

Completeness (%)

100 (100)

Multiplicity

10.2 (7.1)

Rmerge

0.051 (0.574)

Refinement
No. of used reflections

44,828

Rwork (%)

0.149

Rfree (%)

0.164

Mean B factor (Å2)

17.9

RMSD bonds (Å)

0.006

RMSD angles (°)

1.146
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Model Validation
Clash score, all atoms

2.77

Ramachandran Favored (%)

98.1

Ramachandran Outliers (%)

0

Poor Rotamers (%)

0

MolProbity score
1.06
a
Value in parenthesis are statistics for the highest resolution shell.

S11

a

b

SI Figure 1. Test for PYCR activity in the reverse direction. PYCR activity in the
reverse direction (L-Pro + NAD+  L-P5C + NADH) was assayed using 0.06 µM (a)
HsPYCR1 or (b) HsPYCR2. Assays were performed in 0.1 M Tris-HCl (pH 7.5) buffer
with 0.01% (v/v) Brij-35 detergent, 30 mM MgCl2, 5 mM L-proline, 0.5 mM NAD+, and
with or without 1 mM TCEP or 1 mM THPP. The absorbance at 340 nm was recorded
for 30 min.

a

b

SI Figure 2. Absorbance changes upon mixing NAD+ with tris(alkyl)phosphine
compounds. NAD+ (0.5 mM) was incubated in 0.1 M Tris-HCl (pH 7.5) buffer with
0.01% (v/v) Brij-35 detergent, 30 mM MgCl2, and 5 mM L-proline. After 15 min, (a)
TCEP and (b) THPP were added (1 mM final concentration) and the absorbance was
recorded for an additional 15 min.
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a

b

c

d

SI Figure 3. Stopped-flow absorbance spectrophotometry of mixing NAD+ and
TCEP. NAD+ (0.5 mM after mixing) and TCEP (25 mM after mixing) were rapidly
combined and multiwavelength absorbance traces were recorded. Reactions were
performed in 100 mM (pH 7.5) (a) HEPES, (b) Tris-HCl, (c) Na-Phosphate, and (d) PBS
reaction buffer. Plots of the absorbance increase at 334 nm fit to a single 3 parameter
exponential equation are shown in the inset along with the observed rate constant (kobs).
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δ (1H)

SI Figure 4. Stacked proton NMR spectra of NAD+(blue), NADH (red), and reaction
mixtures of NAD+ with THPP (green) or TCEP (fuchsia).
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δ (31P)

δ (1H)

SI Figure 5. Two-dimensional 1H-31P HSQC-TOCSY spectra of NAD+ and THPP
reaction mixture. The spectrum was acquired with a J(HP)-coupling constant of 11 Hz
and a TOCSY mixing time of 80 ms. The assignment of this spectra is summarized in SI
Table 4. Note the 1H-31P correlations shown here correspond to both NAD+─THPP
reaction product protons and to NAD+ protons.
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a

δ (1H)

δ (1H)

b

δ (1H)

δ (1H)

SI Figure 6. Two-dimensional (a) 1H-1H COSY spectrum and (b) 1H-1H TOCSY
spectrum of NAD+ and THPP reaction mixture.
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a

δ (13C)

δ (1H)

b

δ (13C)

δ (1H)

SI Figure 7. Two-dimensional (a) 1H-13C HSQC spectrum and (b) 1H-13C HMBC
spectrum of NAD+ and THPP reaction mixture. The assignments of these spectra are
summarized in SI Table 5.
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SI Figure 8. Interference of an assay of glucose-6-phosphate dehydrogenase by TCEP.
The bars represent the apparent reaction rate as a function of NAD + and TCEP
concentrations, with G6P fixed at 5 mM. For each NAD+ concentration, the results are
normalized to the rate measured in the absence of TCEP. The error bars represent the
absolute difference between two trials.
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